Cohort study reveals variations in neoadjuvant therapy delivery for pancreatic cancer, suggesting standardization is needed.
There is significant intranetwork variation in access to interventional endoscopy and choice of NAC regimen. Centralised tracking of patients receiving NAC, development of locally agreed treatment protocols and an update to national guidelines are needed to standardise NAC pathways for BR/LAPC.
No takes yet. Share an insight, caveat, or question.
Labib et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: